Cited by 113Protein Kinase Regulation and GTPase SignalingProtein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancer

The B56α Regulatory Subunit of Protein Phosphatase 2A Is a Target for Regulation by Double-Stranded RNA-Dependent Protein Kinase PKR

Open access
Xu, Zan, Williams, Bryan R. G.·2000·Molecular and Cellular Biology

Abstract

PKR is a cellular serine/threonine kinase that phosphorylates eukaryotic translation initiation factor 2alpha (eIF2alpha) to regulate protein synthesis. PKR also plays a role in the regulation of transcription, programmed cell death and the cell cycle, processes which likely involve other substrates. In a yeast two-hybrid screen, we isolated human protein phosphatase 2A (PP2A) regulatory subunit B56alpha as a PKR-interacting protein. The interaction between B56alpha and PKR was confirmed by in vitro binding assays as well as by in vivo coimmunoprecipitation, and this interaction is dependent on the catalytic activity of PKR. Moreover, recombinant B56alpha was efficiently phosphorylated by PKR in vitro and an isoelectric point shift in B56alpha was detected in extracts from cells induced with the PKR activator pIC. An in vitro dephosphorylation assay showed that when B56alpha was phosphorylated by PKR, the activity of PP2A trimeric holoenzyme was increased. A functional interaction between B56alpha and PKR was observed in cotransfection assays, where a B56alpha-mediated increase in luciferase expression was inhibited by cotransfection with wild-type PKR. This is likely due to a decreased level of eIF4E phosphorylation caused by an increase in PP2A activity following PKR phosphorylation of B56alpha. Taken together, our data indicate that PKR can modulate PP2A activity by phosphorylating B56alpha to regulate cellular activities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.20.14.5285-5299.2000

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PKR can induce dephosphorylation of 4E-BPs by increasing the activity of phosphatase 2A after its interaction with the regulatory subunit B56α, leading to cell apoptosis.

    “PKR can induce dephosphorylation of the proteins 4E-BPs by increasing the activity of the phosphatase 2A after its interaction with the regulatory subunit B56α, leading to cell apoptosis [82–84].”

    From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [84]

    The Results and Discussion (page unavailable) support a proposed mechanism in which PKR phosphorylates B56α, increases PP2A activity, and decreases phosphorylation of eIF4E—not 4E-BPs. The Discussion mentions apoptosis only as a possible effect of altered PP2A activity; it does not establish that this pathway leads to apoptosis. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [1]Alberts A S, Deng T, Lin A, Meinkoth J L, Schonthal A, Mumby M C, Karin M, Feramisco J R. Protein phosphatase 2A potentiates activity of promoters containing AP-1-binding elements. Mol Cell Biol. 1993;13:2104–2112. doi: 10.1128/mcb.13.4.2104-2112.1993. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  2. [2]Baharians Z, Schonthal A H. Autoregulation of protein phosphatase type 2A expression. J Biol Chem. 1998;273:19019–19024. doi: 10.1074/jbc.273.30.19019. [DOI] [PubMed] [Google Scholar] · DOI
  3. [3]Balachandran S, Kim C N, Yeh W C, Mak T W, Bhalla K, Barber G N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 1998;17:6888–6902. doi: 10.1093/emboj/17.23.6888. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  4. [4]Barber G N, Wambach M, Thompson S, Jagus R, Katze M G. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol. 1995;15:3138–3146. doi: 10.1128/mcb.15.6.3138. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  5. [5]Boyle W J, van der Geer P, Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 1991;201:110–149. doi: 10.1016/0076-6879(91)01013-r. [DOI] [PubMed] [Google Scholar] · DOI
  6. [6]Buss W C, Stepanek J, Queen S A. Association of tissue-specific changes in translation elongation after cyclosporin with changes in elongation factor 2 phosphorylation. Biochem Pharmacol. 1994;48:1459–1469. doi: 10.1016/0006-2952(94)90571-1. [DOI] [PubMed] [Google Scholar] · DOI
  7. [7]Cai R, Williams B R G. Mutations in the double-stranded RNA-activated protein kinase insert region that uncouple catalysis from eIF2alpha binding. J Biol Chem. 1998;273:11274–11280. doi: 10.1074/jbc.273.18.11274. [DOI] [PubMed] [Google Scholar] · DOI
  8. [8]Carpick B W, Graziano V, Schneider D, Maitra R K, Lee X, Williams B R G. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J Biol Chem. 1997;272:9510–9516. doi: 10.1074/jbc.272.14.9510. [DOI] [PubMed] [Google Scholar] · DOI
  9. [9]Chen J, Martin B L, Brautigan D L. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science. 1992;257:1261–1264. doi: 10.1126/science.1325671. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  10. [10]Chen S C, Kramer G, Hardesty B. Isolation and partial characterization of an Mr 60,000 subunit of a type 2A phosphatase from rabbit reticulocytes. J Biol Chem. 1989;264:7267–7275. [PubMed] [Google Scholar]
  11. [11]Chong K L, Feng L, Schappert K, Meurs E, Donahue T F, Friesen J D, Hovanessian A G, Williams B R G. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 1992;11:1553–1562. doi: 10.1002/j.1460-2075.1992.tb05200.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  12. [12]Chu W M, Ostertag D, Li Z W, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity. 1999;11:721–731. doi: 10.1016/s1074-7613(00)80146-6. [DOI] [PubMed] [Google Scholar] · DOI
  13. [13]Clemens M J, Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res. 1997;17:503–524. doi: 10.1089/jir.1997.17.503. [DOI] [PubMed] [Google Scholar] · DOI
  14. [14]Cuddihy A R, Li S, Tam N W, Wong A H, Taya Y, Abraham N, Bell J C, Koromilas A E. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol. 1999;19:2475–2484. doi: 10.1128/mcb.19.4.2475. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  15. [16]Deng X, Ito T, Carr B, Mumby M, May W S., Jr Reversible phosphorylation of bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J Biol Chem. 1998;273:34157–34163. doi: 10.1074/jbc.273.51.34157. [DOI] [PubMed] [Google Scholar] · DOI
  16. [17]Der S D, Yang Y L, Weissmann C, Williams B R G. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci USA. 1997;94:3279–3283. doi: 10.1073/pnas.94.7.3279. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  17. [18]Galabru J, Katze M G, Robert N, Hovanessian A G. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem. 1989;178:581–589. doi: 10.1111/j.1432-1033.1989.tb14485.x. [DOI] [PubMed] [Google Scholar] · DOI
  18. [19]Goedert M, Cohen E S, Jakes R, Cohen P. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease. FEBS Lett. 1992;312:95–99. doi: 10.1016/0014-5793(92)81418-l. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  19. [20]Goh K C, Haque S J, Williams B R G. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 1999;18:5601–5608. doi: 10.1093/emboj/18.20.5601. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  20. [21]Heriche J K, Lebrin F, Rabilloud T, Leroy D, Chambaz E M, Goldberg Y. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science. 1997;276:952–955. doi: 10.1126/science.276.5314.952. [DOI] [PubMed] [Google Scholar] · DOI
  21. [22]Hovanessian A G. Double-stranded RNA dependent protein kinase(s) in rabbit reticulocyte lysates analogous to kinase from interferon-treated cells. Biochimie. 1980;62:775–778. doi: 10.1016/s0300-9084(80)80132-5. [DOI] [PubMed] [Google Scholar] · DOI
  22. [23]Iordanov M S, Paranjape J M, Zhou A, Wong J, Williams B R G, Meurs E F, Silverman R H, Magun B E. Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol. 2000;20:617–627. doi: 10.1128/mcb.20.2.617-627.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  23. [24]Ito T, Jagus R, May W S. Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA. 1994;91:7455–7459. doi: 10.1073/pnas.91.16.7455. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  24. [25]Joshi B, Cai A L, Kaper B D, Minich W B, Mandez R, Beach C M, Stepinski J, Darzynkiewicz E, Rhoads R M. Phosphorylation of eukaryotic protein synthesis factor 4E at ser-209. J Biol Chem. 1995;270:14597–14603. doi: 10.1074/jbc.270.24.14597. [DOI] [PubMed] [Google Scholar] · DOI
  25. [26]Kao P N, Chen L, Brock G, Ng J, Kenny J, Smith A J, Corthesy B. Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem. 1994;269:20691–20699. [PubMed] [Google Scholar]
  26. [27]Kleijn M, Vrins C L, Voorma H O, Thomas A A. Phosphorylation state of the cap-binding protein eIF4E during viral infection. Virology. 1996;217:486–494. doi: 10.1006/viro.1996.0143. [DOI] [PubMed] [Google Scholar] · DOI
  27. [28]Koromilas A E, Roy S, Barber G N, Katze M G, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 1992;257:1685–1689. doi: 10.1126/science.1382315. [DOI] [PubMed] [Google Scholar] · DOI
  28. [29]Kumar A, Yang Y L, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams B R G. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 1997;16:406–416. doi: 10.1093/emboj/16.2.406. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  29. [30]Laurent A G, Krust B, Galabru J, Svab J, Hovanessian A G. Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc Natl Acad Sci USA. 1985;82:4341–4345. doi: 10.1073/pnas.82.13.4341. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  30. [31]Lawrence J C, Jr, Fadden P, Haystead T A, Lin T A. PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. Adv Enzyme Regul. 1997;37:239–267. doi: 10.1016/s0065-2571(96)00016-7. [DOI] [PubMed] [Google Scholar] · DOI
  31. [32]Lee T H, Solomon M J, Mumby M C, Kirschner M W. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell. 1991;64:415–423. doi: 10.1016/0092-8674(91)90649-j. [DOI] [PubMed] [Google Scholar] · DOI
  32. [33]Lengyel P. Tumor-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA. 1993;90:5893–5895. doi: 10.1073/pnas.90.13.5893. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  33. [34]Luban J, Goff S P. The yeast two-hybrid system for studying protein-protein interactions. Curr Opin Biotechnol. 1995;6:59–64. doi: 10.1016/0958-1669(95)80010-7. [DOI] [PubMed] [Google Scholar] · DOI
  34. [35]Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L, Westendorf J M. Identification of novel M phase phosphoproteins by expression cloning. Mol Biol Cell. 1996;7:1455–1469. doi: 10.1091/mbc.7.9.1455. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  35. [36]McCright B, Rivers A M, Audlin S, Virshup D M. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem. 1996;271:22081–22089. doi: 10.1074/jbc.271.36.22081. [DOI] [PubMed] [Google Scholar] · DOI
  36. [37]McCright B, Virshup D M. Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem. 1995;270:26123–26128. doi: 10.1074/jbc.270.44.26123. [DOI] [PubMed] [Google Scholar] · DOI
  37. [38]Meurs E, Chong K, Galabru J, Thomas N S, Kerr I M, Williams B R G, Hovanessian A G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 1990;62:379–390. doi: 10.1016/0092-8674(90)90374-n. [DOI] [PubMed] [Google Scholar] · DOI
  38. [39]Meurs E F, Galabru J, Barber G N, Katze M G, Hovanessian A G. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA. 1993;90:232–236. doi: 10.1073/pnas.90.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  39. [40]Mumby M C, Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev. 1993;73:673–699. doi: 10.1152/physrev.1993.73.4.673. [DOI] [PubMed] [Google Scholar] · DOI
  40. [41]Mundschau L J, Faller D V. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J Biol Chem. 1995;270:3100–3106. doi: 10.1074/jbc.270.7.3100. [DOI] [PubMed] [Google Scholar] · DOI
  41. [42]Patel R C, Sen G C. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 1998;17:4379–4390. doi: 10.1093/emboj/17.15.4379. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  42. [43]Patel R C, Vestal D J, Xu Z, Bandyopadhyay S, Guo W, Erme S M, Williams B R G, Sen G C. DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J Biol Chem. 1999;274:20432–20437. doi: 10.1074/jbc.274.29.20432. [DOI] [PubMed] [Google Scholar] · DOI
  43. [44]Romano P R, Garcia-Barrio M T, Zhang X, Wang Q, Taylor D R, Zhang F, Herring C, Mathews M B, Qin J, Hinnebusch A G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2α kinases PKR and GCN2. Mol Cell Biol. 1998;18:2282–2297. doi: 10.1128/mcb.18.4.2282. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  44. [45]Santoro M F, Annand R R, Robertson M M, Peng Y W, Brady M J, Mankovich J A, Hackett M C, Ghayur T, Walter G, Wong W W, Giegel D A. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem. 1998;273:13119–13128. doi: 10.1074/jbc.273.21.13119. [DOI] [PubMed] [Google Scholar] · DOI
  45. [46]Schonthal A H. Role of PP2A in intracellular signal transduction pathways. Front Biosci. 1998;3:D1262–D1273. doi: 10.2741/A361. [DOI] [PubMed] [Google Scholar] · DOI
  46. [47]Seeling J M, Miller J R, Gil R, Moon R T, White R, Virshup D M. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science. 1999;283:2089–2091. doi: 10.1126/science.283.5410.2089. [DOI] [PubMed] [Google Scholar] · DOI
  47. [48]Sontag E, Nunbhakdi-Craig V, Bloom G S, Mumby M C. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol. 1995;128:1131–1144. doi: 10.1083/jcb.128.6.1131. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  48. [49]Sontag E, Sontag J M, Garcia A. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J. 1997;16:5662–5671. doi: 10.1093/emboj/16.18.5662. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  49. [50]Szyszka R, Kudlicki W, Kramer G, Hardesty B, Galabru J, Hovanessian A. A type 1 phosphoprotein phosphatase active with phosphorylated Mr = 68,000 initiation factor 2 kinase. J Biol Chem. 1989;264:3827–3831. [PubMed] [Google Scholar]
  50. [51]Taylor D R, Lee S B, Romano P R, Marshak D R, Hinnebusch A G, Esteban M, Mathews M B. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol. 1996;16:6295–6302. doi: 10.1128/mcb.16.11.6295. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  51. [52]Vlach J, Garcia A, Jacque J M, Rodriguez M S, Michelson S, Virelizier J L. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology. 1995;208:753–761. doi: 10.1006/viro.1995.1207. [DOI] [PubMed] [Google Scholar] · DOI
  52. [53]Wang S S, Esplin E D, Li J L, Huang L, Gazdar A, Minna J, Evans G A. Alterations of the PPP2R1B gene in human lung and colon cancer. Science. 1998;282:284–287. doi: 10.1126/science.282.5387.284. [DOI] [PubMed] [Google Scholar] · DOI
  53. [54]Wera S, Hemmings B A. Serine/threonine protein phosphatases. Biochem J. 1995;311:17–29. doi: 10.1042/bj3110017. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  54. [55]Westphal R S, Anderson K A, Means A R, Wadzinski B E. A signaling complex of Ca2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science. 1998;280:1258–1261. doi: 10.1126/science.280.5367.1258. [DOI] [PubMed] [Google Scholar] · DOI
  55. [56]Williams B R G. PKR; a sentinel kinase for cellular stress. Oncogene. 1999;18:6112–6120. doi: 10.1038/sj.onc.1203127. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  56. [57]Williams B R G. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans. 1997;25:509–513. doi: 10.1042/bst0250509. [DOI] [PubMed] [Google Scholar] · DOI
  57. [58]Wong A H, Tam N W, Yang Y L, Cuddihy A R, Li S, Kirchhoff S, Hauser H, Decker T, Koromilas A E. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 1997;16:1291–1304. doi: 10.1093/emboj/16.6.1291. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  58. [59]Yang Y L, Reis L F, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams B R G, Aguet M, Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 1995;14:6095–6106. doi: 10.1002/j.1460-2075.1995.tb00300.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  59. [60]Yue Z, Shatkin A J. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology. 1997;234:364–371. doi: 10.1006/viro.1997.8664. [DOI] [PubMed] [Google Scholar] · DOI
  60. [61]Zamanian-Daryoush M, Der S D, Williams B R G. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR. Oncogene. 1999;18:315–326. doi: 10.1038/sj.onc.1202293. [DOI] [PubMed] [Google Scholar] · DOI
  61. [62]Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 1998;281:1360–1363. doi: 10.1126/science.281.5381.1360. [DOI] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Xu, Z., & Williams, B. R. G.
Affiliations
Cleveland Clinic (US)
Venue
Molecular and Cellular Biology
Published
2000-07
Volume
20
Issue
14
Pages
5285-5299
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2076945543
Cited by
113
References
1
Citations by year
2026: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 1 · 2014: 3 · 2013: 6 · 2012: 3
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (AI 34039-02, R01AI034039)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
PKR, protein phosphatase 2A, double-stranded RNA-dependent protein kinase, protein phosphorylation, eIF2α, eIF4E phosphorylation, protein-protein interaction, translational regulation
MeSH terms
Animals, Cells, Cultured, Enzyme Activation, Humans, Isoelectric Point, Mice, Inbred C57BL, Peptide Initiation Factors, Phosphoprotein Phosphatases, Phosphorylation, Precipitin Tests, Serine, Substrate Specificity, Threonine, Transfection, eIF-2 Kinase, Two-Hybrid System Techniques, Eukaryotic Initiation Factor-4E, Mice, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review